Company intelligence / Profile preview

Mintech-Bio

Nottingham, Nottinghamshire, United Kingdommintech.bio ↗

Ownership: Private
Development stage: Other

Overview

Mintech-Bio is developing a proprietary biomaterial platform for dental enamel regeneration, with promising preclinical research published in high-impact journals and over $3.2 million in grant-driven investment. The company has secured its first patent and is expanding R&D operations in the UK and US[1][4].

Therapeutic areas: Other
Modalities: BiologicBiomaterial-based therapy (Enamel regeneration)
Industry: Biotech

Partnerships

Strategic partnerships planned for US-based R&D operations, but specific partners not named yet[1]

Beyond the preview

Go deeper on Mintech-Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mintech-Bio.

Explore the full profile